Dimed S.A. Distribuidora de Medicamentos Asset Resilience Ratio
Dimed S.A. Distribuidora de Medicamentos asset resilience ratio. Dimed S.A. Distribuidora de Medicamentos (PNVL3) has an Asset Resilience Ratio of 6.34% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Dimed S.A. Distribuidora de Medicamentos (PNVL3) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Dimed S.A. Distribuidora de Medicamentos (2000–2025)
Asset resilience ratio of Dimed S.A. Distribuidora de Medicamentos from 2000 to 2025. This chart shows how Dimed S.A. Distribuidora de Medicamentos's Asset Resilience Ratio has changed over time. Read PNVL3 current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Dimed S.A. Distribuidora de Medicamentos's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Dimed S.A. Distribuidora de Medicamentos.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$0.00 | 0% |
| Short-term Investments | R$235.20 Million | 6.34% |
| Total Liquid Assets | R$235.20 Million | 6.34% |
Asset Resilience Insights
- Limited Liquidity: Dimed S.A. Distribuidora de Medicamentos maintains only 6.34% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Dimed S.A. Distribuidora de Medicamentos Industry Peers by Asset Resilience Ratio
Compare Dimed S.A. Distribuidora de Medicamentos's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Novartis AG
SW:NOVN |
Drug Manufacturers - General | 0.08% |
|
Virbac SA
PA:VIRP |
Drug Manufacturers - General | 0.23% |
|
AstraZeneca PLC
LSE:AZN |
Drug Manufacturers - General | 0.06% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771 |
Drug Manufacturers - General | 1.97% |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
Drug Manufacturers - General | 5.37% |
|
Firebrick Pharma Ltd
AU:FRE |
Drug Manufacturers - General | 0.29% |
|
Eli Lilly and Company
SA:LILY34 |
Drug Manufacturers - General | 6.46% |
Dimed S.A. Distribuidora de Medicamentos Asset Resilience Ratio by Year (2000–2025)
Dimed S.A. Distribuidora de Medicamentos asset resilience ratio by year from 2000 to 2025. The table below shows the annual Asset Resilience Ratio data for Dimed S.A. Distribuidora de Medicamentos.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 10.70% | R$410.05 Million ≈ $80.46 Million |
R$3.83 Billion ≈ $751.62 Million |
+4.56pp |
| 2024-12-31 | 6.15% | R$207.59 Million ≈ $40.73 Million |
R$3.38 Billion ≈ $662.72 Million |
-1.57pp |
| 2023-12-31 | 7.72% | R$237.48 Million ≈ $46.60 Million |
R$3.08 Billion ≈ $603.86 Million |
+2.14pp |
| 2022-12-31 | 5.58% | R$152.52 Million ≈ $29.93 Million |
R$2.73 Billion ≈ $536.29 Million |
-3.03pp |
| 2021-12-31 | 8.61% | R$205.00 Million ≈ $40.22 Million |
R$2.38 Billion ≈ $467.21 Million |
-11.01pp |
| 2020-12-31 | 19.62% | R$430.63 Million ≈ $84.50 Million |
R$2.19 Billion ≈ $430.58 Million |
+15.68pp |
| 2019-12-31 | 3.95% | R$57.67 Million ≈ $11.32 Million |
R$1.46 Billion ≈ $286.53 Million |
+1.49pp |
| 2018-12-31 | 2.46% | R$24.58 Million ≈ $4.82 Million |
R$1.00 Billion ≈ $196.29 Million |
-2.08pp |
| 2017-12-31 | 4.54% | R$43.09 Million ≈ $8.46 Million |
R$950.17 Million ≈ $186.44 Million |
+3.48pp |
| 2016-12-31 | 1.05% | R$8.62 Million ≈ $1.69 Million |
R$820.97 Million ≈ $161.09 Million |
+0.03pp |
| 2015-12-31 | 1.02% | R$7.73 Million ≈ $1.52 Million |
R$759.97 Million ≈ $149.12 Million |
-1.38pp |
| 2014-12-31 | 2.40% | R$17.26 Million ≈ $3.39 Million |
R$719.27 Million ≈ $141.13 Million |
+0.52pp |
| 2013-12-31 | 1.88% | R$11.28 Million ≈ $2.21 Million |
R$599.89 Million ≈ $117.71 Million |
-1.93pp |
| 2012-12-31 | 3.81% | R$19.09 Million ≈ $3.75 Million |
R$500.82 Million ≈ $98.27 Million |
-8.16pp |
| 2009-12-31 | 11.97% | R$39.88 Million ≈ $7.83 Million |
R$333.08 Million ≈ $65.36 Million |
+11.71pp |
| 2008-12-31 | 0.26% | R$716.00K ≈ $140.49K |
R$275.75 Million ≈ $54.11 Million |
-4.66pp |
| 2007-12-31 | 4.92% | R$12.47 Million ≈ $2.45 Million |
R$253.46 Million ≈ $49.73 Million |
-2.78pp |
| 2006-12-31 | 7.70% | R$18.03 Million ≈ $3.54 Million |
R$234.29 Million ≈ $45.97 Million |
+0.74pp |
| 2005-12-31 | 6.96% | R$15.13 Million ≈ $2.97 Million |
R$217.51 Million ≈ $42.68 Million |
-1.01pp |
| 2004-12-31 | 7.96% | R$14.33 Million ≈ $2.81 Million |
R$179.97 Million ≈ $35.31 Million |
-4.76pp |
| 2003-12-31 | 12.72% | R$21.88 Million ≈ $4.29 Million |
R$172.02 Million ≈ $33.75 Million |
-1.24pp |
| 2002-12-31 | 13.96% | R$20.27 Million ≈ $3.98 Million |
R$145.21 Million ≈ $28.49 Million |
-4.04pp |
| 2001-12-31 | 18.00% | R$28.17 Million ≈ $5.53 Million |
R$156.51 Million ≈ $30.71 Million |
+2.73pp |
| 2000-12-31 | 15.27% | R$22.56 Million ≈ $4.43 Million |
R$147.79 Million ≈ $29.00 Million |
-- |
About Dimed S.A. Distribuidora de Medicamentos
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.